Clinical use of crizotinib for the treatment of non-small cell lung cancer

Discoveries over the last decade have fundamentally transformed the way we define lung cancer. Gone are the days of the simple binary classification system of non-small cell lung cancer (NSCLC) and small cell lung cancer. Today, accurate identification of the histological and molecular subtype of NS...

Descripción completa

Detalles Bibliográficos
Autor principal: Roberts, Patrick J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643289/
https://www.ncbi.nlm.nih.gov/pubmed/23671386
http://dx.doi.org/10.2147/BTT.S29026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643289/
https://www.ncbi.nlm.nih.gov/pubmed/23671386
http://dx.doi.org/10.2147/BTT.S29026

Ejemplares similares